| Old Articles: <Older 28861-28870 Newer> |
|---|
 |
The Motley Fool
February 26, 2008
Jack Uldrich |
Nokia's Small Stretch Nokia unveils "Morph" -- a stretchable and flexible mobile phone. It is only a concept product so far, but it hints at where the future of mobile devices might be headed.   |
The Motley Fool
February 26, 2008
Timothy M. Otte |
Prime Your Portfolio Know and understand the difference between prime and action investments. |
The Motley Fool
February 26, 2008
Tim Hanson |
Will China Save Us All? The Chinese market had a banner 2007, hence saving many micro-cap investors last year. Will they do it again? |
The Motley Fool
February 26, 2008
Anders Bylund |
IBM Builds Servers, VMware Builds Repute VMware announces that its "hypervisor" virtual machine manager will ship pre-installed on server systems from some of the biggest names in the data center. |
The Motley Fool
February 26, 2008
Rich Smith |
Quick Take: Ring That Bell! Presiding over the Nasdaq closing bell has not always been a good move for companies. |
The Motley Fool
February 26, 2008
Alyce Lomax |
Mickey D's Delivers? McDonald's is testing delivery service of its food in Shanghai, China, using a fleet of 300 motorcycles to speed the eats to customers. |
Wall Street & Technology
February 18, 2008
Cory Levine |
Stock Exchanges and ECNs Fight for Liquidity The newer and faster electronic connectivity networks are leveraging aggressive pricing models to quickly catch up to their established exchange counterparts. |
The Motley Fool
February 25, 2008
Anders Bylund |
3 Stocks That Missed the Mark These companies overpromised and underdelivered: Whole Foods... Suntech Power Holdings... CapitalSource... |
The Motley Fool
February 25, 2008
Rick Aristotle Munarriz |
Apple in 2010 Let's take a look ahead and see what Apple may be like two years from now. |
The Motley Fool
February 25, 2008
Brian Orelli |
The Biologic That Keeps on Giving Just a month after Abbott Laboratories receives a fifth approval for its anti-inflammatory Humira, the FDA approved the biotech drug to treat yet another disease. |
| <Older 28861-28870 Newer> Return to current articles. |
